This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burns, J. L.
Right arrow Articles by Goodall, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, J. L.
Right arrow Articles by Goodall, C. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 02 1996, 307-313, Vol 40, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance

JL Burns, CD Wadsworth, JJ Barry and CP Goodall
Division of Infectious Disease, Children's Hospital and Medical Center, Seattle, Washington, USA. jburns@u.washington.edu

Antibiotic-resistant Burkholderia (Pseudomonas) cepacia is an important etiologic agent of nosocomial and cystic fibrosis infections. The primary resistance mechanism which has been reported is decreased outer membrane permeability. We previously reported the cloning and characterization of a chloramphenicol resistance determinant from an isolate of B. cepacia from a patient with cystic fibrosis that resulted in decreased drug accumulation. In the present studies we subcloned and sequenced the resistance determinant and identified gene products related to decreased drug accumulation. Additional drug resistances encoded by the determinant include resistances to trimethoprim and ciprofloxacin. Sequence analysis of a 3.4-kb subcloned fragment identified one complete and one partial open reading frame which are homologous with two of three components of a potential antibiotic efflux operon from Pseudomonas aeruginosa (mexA-mexB-oprM). On the basis of sequence data, outer membrane protein analysis, protein expression systems, and a lipoprotein labelling assay, the complete open reading frame encodes an outer membrane lipoprotein which is homologous with OprM. The partial open reading frame shows homology at the protein level with the C terminus of the protein product of mexB. DNA hybridization studies demonstrated homology of an internal mexA probe with a larger subcloned fragment from B. cepacia. The finding of multiple antibiotic resistance in B. cepacia as a result of an antibiotic efflux pump is surprising because it has long been believed that resistance in this organism is caused by impermeability to antibiotics.


This article has been cited by other articles:

  • Loutet, S. A., Bartholdson, S. J., Govan, J. R. W., Campopiano, D. J., Valvano, M. A. (2009). Contributions of two UDP-glucose dehydrogenases to viability and polymyxin B resistance of Burkholderia cenocepacia. Microbiology 155: 2029-2039 [Abstract] [Full Text]  
  • Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeno-Tarraga, A. M., Thomson, N. R., Bason, N., Quail, M. A., Sharp, S., Cherevach, I., Churcher, C., Goodhead, I., Hauser, H., Holroyd, N., Mungall, K., Scott, P., Walker, D., White, B., Rose, H., Iversen, P., Mil-Homens, D., Rocha, E. P. C., Fialho, A. M., Baldwin, A., Dowson, C., Barrell, B. G., Govan, J. R., Vandamme, P., Hart, C. A., Mahenthiralingam, E., Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients. J. Bacteriol. 191: 261-277 [Abstract] [Full Text]  
  • De Soyza, A., Silipo, A., Lanzetta, R., Govan, J. R., Molinaro, A. (2008). Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides. Innate Immunity 14: 127-144 [Abstract]  
  • Zhou, J., Chen, Y., Tabibi, S., Alba, L., Garber, E., Saiman, L. (2007). Antimicrobial Susceptibility and Synergy Studies of Burkholderia cepacia Complex Isolated from Patients with Cystic Fibrosis. Antimicrob. Agents Chemother. 51: 1085-1088 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]  
  • Vinion-Dubiel, A. D., Goldberg, J. B. (2003). Review: Lipopolysaccharide of Burkholderia cepacia complex. Innate Immunity 9: 201-213 [Abstract]  
  • Marier, J.-F., Lavigne, J., Ducharme, M. P. (2002). Pharmacokinetics and Efficacies of Liposomal and Conventional Formulations of Tobramycin after Intratracheal Administration in Rats with Pulmonary Burkholderia cepacia Infection. Antimicrob. Agents Chemother. 46: 3776-3781 [Abstract] [Full Text]  
  • Wigfield, S. M., Rigg, G. P., Kavari, M., Webb, A. K., Matthews, R. C., Burnie, J. P. (2002). Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J Antimicrob Chemother 49: 619-624 [Abstract] [Full Text]  
  • Chopra, I., Roberts, M. (2001). Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol. Mol. Biol. Rev. 65: 232-260 [Abstract] [Full Text]  
  • Li, X.-Z., Poole, K. (2001). Mutational Analysis of the OprM Outer Membrane Component of the MexA-MexB-OprM Multidrug Efflux System of Pseudomonas aeruginosa. J. Bacteriol. 183: 12-27 [Abstract] [Full Text]  
  • Poole, K. (2000). Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria. Antimicrob. Agents Chemother. 44: 2233-2241 [Full Text]  
  • Wong, K. K. Y., Hancock, R. E. W. (2000). Insertion Mutagenesis and Membrane Topology Model of the Pseudomonas aeruginosa Outer Membrane Protein OprM. J. Bacteriol. 182: 2402-2410 [Abstract] [Full Text]  
  • Sajjan, U. S., Sylvester, F. A., Forstner, J. F. (2000). Cable-Piliated Burkholderia cepacia Binds to Cytokeratin 13 of Epithelial Cells. Infect. Immun. 68: 1787-1795 [Abstract] [Full Text]  
  • FRANGOLIAS, D. D., MAHENTHIRALINGAM, E., RAE, S., RABOUD, J. M., DAVIDSON, A. G. F., WITTMANN, R., WILCOX, P. G. (1999). Burkholderia cepacia in Cystic Fibrosis . Variable Disease Course. Am. J. Respir. Crit. Care Med. 160: 1572-1577 [Abstract] [Full Text]  
  • Pearson, J. P., Van Delden, C., Iglewski, B. H. (1999). Active Efflux and Diffusion Are Involved in Transport of Pseudomonas aeruginosa Cell-to-Cell Signals. J. Bacteriol. 181: 1203-1210 [Abstract] [Full Text]  
  • Bonacorsi, S., Fitoussi, F., Lhopital, S., Bingen, E. (1999). Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis. Antimicrob. Agents Chemother. 43: 213-217 [Abstract] [Full Text]  
  • Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S., Nishino, T. (1999). Interplay between Chromosomal beta -Lactamase and the MexAB-OprM Efflux System in Intrinsic Resistance to beta -Lactams in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: 400-402 [Abstract] [Full Text]  
  • Evans, K., Passador, L., Srikumar, R., Tsang, E., Nezezon, J., Poole, K. (1998). Influence of the MexAB-OprM Multidrug Efflux System on Quorum Sensing in Pseudomonas aeruginosa. J. Bacteriol. 180: 5443-5447 [Abstract] [Full Text]